China-based startup ElpasBio Holdings, a leading clinical-stage biotechnology company focused on regenerative medicine, ...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Cente...
The Hong Kong Polytechnic University (PolyU) has developed an acid-resistant “ultra-stable mucus-inspired hydrogel...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
Germany-based Merz Aesthetics, the world’s largest dedicated medical aesthetics business, has launched flagship pr...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology th...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
Pillar Biosciences and AstraZeneca have announced an expansion of their existing laboratory access programme for NG...
Biosparc’s landmark project in Suzhou Industrial Park reached structural completion. On 20 November 2025 the firm ...
